Initiation of or modifications in medications should be made in conjunction with neurologist
Dopamine agonists
Levodopa and carbidopa (peripheral decarboxylase inhibitor) = gold standard
Pramipexole (Mirapex)
Ropinirole (Requip)
Anticholinergics
Benztropine - caution in acute psychosis
Monoamine oxidase inhibitor - blocks DA reuptake
Selegiline (Eldepryl)
Rasagiline (Azilect)
Agents for psychotic symptoms, hallucinations
Pimavanserin (Nuplazaid) - serotonin inverse agonist (not anti-dopamine), FDA approved in 2016
Avoid antidopaminergic drugs if possible (expect worsening motor symptoms), but commonly used agents:
Olanzapine
Quetiapine
Others:
Rivastigmine
Citalopram in depressed patients
Levodopa and carbidopa (peripheral decarboxylase inhibitor) = gold standard
Pramipexole (Mirapex)
Ropinirole (Requip)
Benztropine - caution in acute psychosis
Selegiline (Eldepryl)
Rasagiline (Azilect)
Pimavanserin (Nuplazaid) - serotonin inverse agonist (not anti-dopamine), FDA approved in 2016
Avoid antidopaminergic drugs if possible (expect worsening motor symptoms), but commonly used agents:
Olanzapine
Quetiapine
Others:
Rivastigmine
Citalopram in depressed patients
Olanzapine
Quetiapine
Rivastigmine
Citalopram in depressed patients
Parkinson's disease
Degenerative
Dementia with Lewy bodies
Alzheimer's disease
Sydenham's chorea
Huntington's disease
Prion disease
Dementia